Clinical Trial Update: FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) Test [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating functional RECAP-guided selection of advanced breast cancer patients for talazoparib treatment; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Advanced Breast Cancer | Phase 2 | Status: RECRUITING